Panagora Asset Management Inc Inovio Pharmaceuticals, Inc. Transaction History

Panagora Asset Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$1.97 - $3.72 $112,325 - $212,106	-57,018 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$2.05 - $3.02 $212,535 - $313,101	-103,676 Reduced 64.52%	57,018 $117,000
Q2 2019 Aug 09, 2019	SELL	$2.29 - $4.1 $2.06 Million - $3.69 Million	-899,731 Reduced 84.85%	160,694 $472,000
Q1 2019 May 15, 2019	BUY	$3.34 - $5.1 $1.15 Million - $1.75 Million	342,966 Added 47.8%	1,060,425 $3.96 Million
Q4 2018 Feb 14, 2019	BUY	$3.89 - $6.11 $275,404 - $432,575	70,798 Added 10.95%	717,459 $2.87 Million
Q3 2018 Nov 13, 2018	BUY	$3.92 - $5.58 $1.24 Million - $1.77 Million	316,457 Added 95.84%	646,661 $3.6 Million
Q2 2018 Aug 14, 2018	SELL	$3.88 - $5.16 $1.84 Million - $2.44 Million	-473,142 Reduced 58.9%	330,204 $1.29 Million
Q1 2018 May 15, 2018	BUY	$4.05 - $5.69 $543,271 - $763,262	134,141 Added 20.04%	803,346 $3.78 Million
Q4 2017 Feb 14, 2018	SELL	$4.13 - $6.68 $137,004 - $221,595	-33,173 Reduced 4.72%	669,205 $2.76 Million
Q3 2017 Nov 14, 2017	BUY	$5.36 - $6.37 $3.76 Million - $4.47 Million	702,378	702,378 $4.45 Million

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $494M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.